Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-05

Clinical Trial Update: Study Evaluating the Effect of Food on the Bioavailability of PN400 Components [Phase 1]

View source ↗

Summary

Phase 1 trial by POZEN assessing the effect of food on the bioavailability of PN400 components in arthritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PN400 components

Snippet

Sponsor: POZEN | Conditions: Arthritis | Phase 1 | Status: COMPLETED